trastuzumab deruxtecan,ruxolitinib
astrazeneca,daiichi sankyo,incyte,novartis
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)']
 evolving options for her2-directed therapies in #crc
#asco23 by 
Physician-scientist, focused on translational research in hepatobiliary cancer and precision oncology